In a recent post about the ongoing EpiPen pricing saga, I suggested that a case study might be unfolding before our eyes: for the first time I can remember, “consumerism” actually seems to be influencing health care prices. This is part two of that story.
Here’s a quick overview of the Senate report about predatory drug pricing. [Los Angeles Times]
Sudden Price Spikes in Off-Patent Prescription Drugs: The Monopoly Business Model that Harms Patients, Taxpayers, and the U.S. Health Care System
Here’s the 131-page Senate report about pharmaceutical companies that have raised the price of life-saving drugs as much as 5,000%. It’s not just EpiPen… [U.S. Senate Special Committee on Aging]
For years, insurance experts have used LASIK surgery as proof that “consumerism” in health care…
As of January 1, 2011, over-the-counter drugs purchased without a prescription are no longer an eligible expense under an FSA, HRA, or HSA.